Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Oct 16.
doi: 10.14336/AD.2025.1087. Online ahead of print.

The Role of Mitochondria-Associated Endoplasmic Reticulum Membranes in Fibrotic Diseases

Affiliations
Review

The Role of Mitochondria-Associated Endoplasmic Reticulum Membranes in Fibrotic Diseases

Fei Wang et al. Aging Dis. .

Abstract

Fibrotic diseases are characterized by high incidence and mortality rates, posing substantial challenges to global public health due to their considerable disease burden. Mitochondrial damage is a common feature in all fibrotic diseases. Mitochondria do not function in isolation; rather, they are often influenced by stress signals from adjacent organelles. Mitochondria and the endoplasmic reticulum are frequently studied as a subfunctional unit. Mitochondria-associated endoplasmic reticulum membranes (MAM) serve as physical connectors between mitochondria and the endoplasmic reticulum. MAM plays a pivotal role in multiple pathological and physiological processes, including lipid metabolism, inflammation, mitochondrial function, cell death, and cellular senescence. These pathological processes are also implicated in the progression of fibrotic diseases. In this review, we examine the relationship between MAM and key pathological mechanisms in fibrotic diseases, such as cell death, cellular senescence, and inflammation. We further explore the potential of MAM as diagnostic biomarkers and therapeutic targets for fibrotic diseases, thereby offering novel research directions and treatment strategies aimed at improving outcomes for patients with fibrotic diseases.

PubMed Disclaimer